Breaking News Instant updates and real-time market news.

LUV

Southwest

$54.00

-0.33 (-0.61%)

, BA

Boeing

$380.41

-2.52 (-0.66%)

20:23
09/30/19
09/30
20:23
09/30/19
20:23

SouthWest pilots warn 737Max may not resume flights until March, Bloomberg says

The pilots of SouthWest Airlines (LUV) are warning that Boeing's (BA) 737 Max aircraft may not resume flights until as late as March, Bloomberg's Mary Schlangenstein writes. The report notes that the airline's internal plans anticipate that the company will not book paying customers on the aircraft until about 45-60 days after the FAA lifts its no-fly order on the plane. January is seen as the earliest possible time when SouthWest Airlines will book 737 Max flights, the report states. Reference Link

LUV

Southwest

$54.00

-0.33 (-0.61%)

BA

Boeing

$380.41

-2.52 (-0.66%)

  • 02

    Oct

  • 23

    Oct

  • 24

    Oct

  • 13

    Nov

  • 12

    Dec

LUV Southwest
$54.00

-0.33 (-0.61%)

08/16/19
WOLF
08/16/19
UPGRADE
WOLF
Outperform
Southwest upgraded to Outperform from Peer Perform at Wolfe Research
09/06/19
BREN
09/06/19
INITIATION
Target $57
BREN
Hold
Southwest initiated with a Hold at Berenberg
Berenberg started Southwest Airlines with a Hold rating and $57 price target.
09/06/19
BREN
09/06/19
INITIATION
BREN
Berenberg says big 4 airlines can generate cash, prefers American and Delta
As previously reported, Berenberg analyst Adrian Yanoshik initiated coverage of the four largest U.S. airlines, starting American Airlines (AAL) with a Buy rating and $35 price target, Delta Air Lines (DAL) with a Buy rating and $72 price target, United Continental (UAL) with a Hold rating and $95 price target and Southwest Airlines (LUV) with a Hold rating and $57 price target. Amid market worries over both capacity growth and demand weakness, his work suggests that U.S. airlines can generate free cash flow in "all scenarios but a 9/11-scale shock," Yanoshik tells investors. He thinks airline sector valuations reflect fears, but overlook broadly stable, albeit two-tiered, returns. He would buy American with valuation at multi-year lows as he estimates that American will narrow its margin gap to peers and thinks it debt burden is misunderstood. He would also buy Delta, which Yanoshik calls "arguably the highest-quality airline."
09/13/19
MACQ
09/13/19
UPGRADE
Target $67
MACQ
Outperform
Southwest upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Susan Donofrio upgraded Southwest to Outperform from Neutral and raised her price target on the shares to $67 from $52.
BA Boeing
$380.41

-2.52 (-0.66%)

09/12/19
09/12/19
UPGRADE
Target $23

Buy
Embraer upgraded to Buy from Neutral at UBS
As previously reported, UBS analyst Myles Walton upgraded Embraer (ERJ) to Buy and raised his price target to $23 from $22, citing the approaching closing of its acquisition by Boeing (BA). The analyst notes that while he sees the possibility of that closing being delayed because of the stalling approval by China regulators, he does not see a significant risk of it being blocked. Walton adds that RemainCo catalysts beyond the tie-up are appearing, citing Embraer's first delivery of KC-390 aircraft to Brazilian air force earlier this month, with another expected to be delivered in Q4.
09/12/19
MSCO
09/12/19
NO CHANGE
Target $500
MSCO
Overweight
Boeing CEO update at Laguna conference 'encouraging,' says Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani called Boeing CEO Dennis Muilenburg's update at the firm's Laguna conference "encouraging," noting that he reported that the 737 MAX certification process is progressing with no major setbacks. Muilenburg still sees the MAX returning to service in Q4, though he acknowledged that approval timing from global regulators and a collaborative approach among them are risks that could contribute to timing delays or a production halt, said Lalwani. Widebody risks are rising due to trade disputes, though they are contained for now, while 777X headwinds are mounting, there is no shift in the recently amended timeline, added Lalwani. Following the CEO presentation, the analyst maintains his Overweight rating and $500 price target on Boeing shares.
09/24/19
LEHM
09/24/19
NO CHANGE
LEHM
Barclays sees aerospace aftermarket stocks continuing to outperform in 2020
Barclays analyst David Strauss' analysis of global airline flight schedules indicates ~3% flight hour growth through the end of 2019, or 200 to 250 basis points below typical levels, due to the combination of the Boeing (BA) MAX grounding and weaker underlying traffic demand. The analyst forecasts decelerating second half of 2019 aftermarket growth as a result, given airlines dependency on older out-of-warranty aircraft. However, even with expected return of MAX in 2020, he forecasts that the aftermarket still grows 6%-8% as incremental MAX flight hours "do little to dilute contribution of continued strong growth in the older out-of-warranty fleet, which is responsible for the majority of aftermarket demand." Among his coverage, Strauss says TransDigm (TDG) is the primary beneficiary of continued aftermarket strength while Woodward (WWD) also has significant exposure. He believes the aerospace aftermarket stocks will continue to outperform in 2020 "despite elevated relative valuations."
09/27/19
BUCK
09/27/19
NO CHANGE
Target $395
BUCK
Neutral
Boeing may rise to $425-$450 when investors gain MAX visibility, says Buckingham
Buckingham analyst Richard Safran maintains a Neutral rating on Boeing, citing end cycle concerns, but tells investors in a research note that he remains "tactically bullish" as he thinks the stock could bounce above his $395 price target short-term as 737 MAX risk dissipates. When investors gain visibility that the MAX will be certified, Safran says he expects a significant amount of buying and believes the stock could rise to $425-$450.

TODAY'S FREE FLY STORIES

AMX

America Movil, also tag AMOV

$15.92

0.02 (0.13%)

, AMOV

America Movil, also tag AMX

$15.70

(0.00%)

15:46
11/11/19
11/11
15:46
11/11/19
15:46
Periodicals
Mexican regulator probing 'monopolistic' mobile phone practices, Bloomberg says »

The IFT investigative…

AMX

America Movil, also tag AMOV

$15.92

0.02 (0.13%)

AMOV

America Movil, also tag AMX

$15.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$2.94

-0.165 (-5.31%)

15:37
11/11/19
11/11
15:37
11/11/19
15:37
Hot Stocks
Mallinckrodt says Phase 3 CONFIRM study met primary endpoint »

Mallinckrodt announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

FGEN

FibroGen

$35.69

-5.92 (-14.23%)

15:34
11/11/19
11/11
15:34
11/11/19
15:34
Options
FibroGen options imply 13.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

FNV

Franco-Nevada

$95.70

0.09 (0.09%)

15:19
11/11/19
11/11
15:19
11/11/19
15:19
Options
Franco-Nevada options imply 4.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MNST

Monster Beverage

$57.81

-0.38 (-0.65%)

15:17
11/11/19
11/11
15:17
11/11/19
15:17
Recommendations
Monster Beverage analyst commentary  »

Monster Beverage said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/11/19
11/11
15:17
11/11/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/11/19
11/11
15:16
11/11/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$29.63

-0.45 (-1.50%)

15:04
11/11/19
11/11
15:04
11/11/19
15:04
Options
DXC Technology options imply 23.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

MRK

Merck

$83.09

-0.5 (-0.60%)

15:01
11/11/19
11/11
15:01
11/11/19
15:01
Hot Stocks
Merck reports ERVEBO vaccine granted conditional approval in EU »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

BTI

British American Tobacco

$37.41

0.38 (1.03%)

, MO

Altria Group

$46.49

0.08 (0.17%)

14:51
11/11/19
11/11
14:51
11/11/19
14:51
Hot Stocks
Trump says will meet with representatives of the vaping industry »

U.S. President Donald…

BTI

British American Tobacco

$37.41

0.38 (1.03%)

MO

Altria Group

$46.49

0.08 (0.17%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$83.70

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

WMGI

Wright Medical

$29.39

-0.01 (-0.03%)

14:49
11/11/19
11/11
14:49
11/11/19
14:49
Options
Wright Medical options imply 3.5% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COG

Cabot Oil & Gas

$17.86

-0.515 (-2.80%)

14:45
11/11/19
11/11
14:45
11/11/19
14:45
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.72

-0.08 (-0.15%)

, USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

14:27
11/11/19
11/11
14:27
11/11/19
14:27
Periodicals
Total CEO sees weak oil demand growth next year, Bloomberg says »

Total CEO Patrick…

TOT

Total

$54.72

-0.08 (-0.15%)

USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

, ACN

Accenture

$189.95

0.34 (0.18%)

14:25
11/11/19
11/11
14:25
11/11/19
14:25
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

ACN

Accenture

$189.95

0.34 (0.18%)

WPP

WPP

$64.60

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

WPP

WPP

$64.60

-0.01 (-0.02%)

, ACN

Accenture

$190.05

0.44 (0.23%)

14:21
11/11/19
11/11
14:21
11/11/19
14:21
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

WPP

WPP

$64.60

-0.01 (-0.02%)

ACN

Accenture

$190.05

0.44 (0.23%)

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

MS

Morgan Stanley

$49.30

0.15 (0.31%)

14:20
11/11/19
11/11
14:20
11/11/19
14:20
Options
Heavy bullish option flow in Morgan Stanley January term »

Heavy bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

BABA

Alibaba

$186.42

-0.69 (-0.37%)

, AAPL

Apple

$261.99

1.79 (0.69%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Hot Stocks
Alibaba reports 11.11 gross merchandise volume grew 26% year-over-year to $38.4B »

Alibaba Group (BABA)…

BABA

Alibaba

$186.42

-0.69 (-0.37%)

AAPL

Apple

$261.99

1.79 (0.69%)

EL

Estee Lauder

$186.46

-0.81 (-0.43%)

GPS

Gap

$17.01

0.32 (1.92%)

LRLCY

L'Oreal

$0.00

(0.00%)

LEVI

Levi Strauss

$17.07

-0.06 (-0.35%)

NSRGY

Nestle

$0.00

(0.00%)

NKE

Nike

$89.89

0.09 (0.10%)

VFC

VF Corp.

$86.52

-0.56 (-0.64%)

UA

Under Armour

$15.81

-0.07 (-0.44%)

UAA

Under Armour

$17.53

-0.02 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 21

    Nov

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/11/19
11/11
14:16
11/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.05

-0.42 (-6.49%)

14:13
11/11/19
11/11
14:13
11/11/19
14:13
Periodicals
CA governor raises objections to $11B PG&E insurance deal, WSJ reports »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Jan

AUPH

Aurinia Pharmaceuticals

$5.05

-0.085 (-1.66%)

14:05
11/11/19
11/11
14:05
11/11/19
14:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary  »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.93

-0.13 (-1.84%)

13:55
11/11/19
11/11
13:55
11/11/19
13:55
Options
Fitbit put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.61

-0.02 (-0.26%)

13:45
11/11/19
11/11
13:45
11/11/19
13:45
Options
Deutsche Bank call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change at Ladenburg »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.